Latest in Reuters Health News
May 16, 2013
| Reuters Health News
By Deena Beasley
(Reuters) – An experimental drug from Gilead Sciences Inc shrank tumors in half of patients with recurrent chronic lymphocytic leukemia (CLL), in an early-stage trial.
The drug, idelalisib, is part of a new class of medications designed to selectively block PI3 kinase delta, a subtype...
May 16, 2013
| Reuters Health News
By Julie Steenhuysen
CHICAGO (Reuters) – Melanoma patients treated with two Bristol-Myers Squibb drugs in an early-stage study fared much better than those who received either drug individually, a new advance for treatments that harness the body’s immune system to fight cancer.
Patients in the...
May 16, 2013
| Reuters Health News
By Kate Kelland
LONDON (Reuters) – Bereaved parents who do not want to see their dead babies go through a conventional autopsy could in the future be offered a less invasive option which uses magnetic resonance imaging (MRI) and blood tests to establish the cause of death.
In a report in The Lancet...
U.S. mercury advisory tied up at health department
May 16, 2013
New Roche leukemia drug may improve on Rituxan
May 15, 2013
Creative arts may ease cancer-related anxiety, pain
May 15, 2013
Warning didn’t change for-profit dialysis drug use
May 15, 2013
Planning can help curb TAVR-related trouble
May 15, 2013
Global life spans continue to lengthen, WHO says
May 15, 2013
Scientists create human stem cells through cloning
May 15, 2013
US sets $1 billion healthcare innovation initiative
May 15, 2013
FDA approves new drug for prostate cancer
May 15, 2013
FDA okays companion diagnostic test for Tarceva
May 15, 2013
Ultra-low salt intake may not boost health: US panel
May 15, 2013
Fewer U.S. uninsured to gain insurance: researchers
May 15, 2013
Outcomes of split liver transplantation “excellent”
May 15, 2013
Hysterectomy not tied to heart risk factors: study
May 15, 2013
Senator says Sebelius should stop fundraising
May 14, 2013
Number of abused U.S. children unchanged since 2008
May 14, 2013
